0

ALINIA از شرکت ROMARK

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ALINIA از شرکت ROMARK

New Drug Application (NDA): 021498

Company: ROMARK

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALINIA NITAZOXANIDE 100MG/5ML FOR SUSPENSION;ORAL Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/22/2002 ORIG-1 Approval

Type 1 – New Molecular Entity

PRIORITY; Orphan

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21498_Alinia_lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21498ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-498_Alinia.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/29/2014 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

07/25/2014 SUPPL-6 Manufacturing (CMC)

Label is not available on this site.

07/11/2016 SUPPL-4 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021497s001,021498s004lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021497Orig1s001,021498Orig1s004ltr.pdf

06/16/2005 SUPPL-3 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021498s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021498s003ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021818s000_021498s003TOC.cfm

07/21/2004 SUPPL-2 Efficacy-New Patient Population

Label is not available on this site.

07/21/2004 SUPPL-1

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21497,21498s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21497,21498s001ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-497_21-498s001_Alinia.cfm

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
07/11/2016 SUPPL-4

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021497s001,021498s004lbl.pdf
06/16/2005 SUPPL-3

Efficacy-New Patient Population

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021498s003lbl.pdf
07/21/2004 SUPPL-1

Supplement

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21497,21498s001lbl.pdf
11/22/2002 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21498_Alinia_lbl.pdf
حتما بخوانید : ALIMTA از شرکت LILLY
برچسب‌ها:

نظرات کاربران